ANDREW HOSSLER: Open Payments
NPI 1710392428 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 44 payments from 15 companies in 2025. Trend: 2023 $1,180 · 2024 $1,056 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $156 |
| AstraZeneca Pharmaceuticals LP | 7 | $113 |
| Viatris Specialty LLC | 5 | $106 |
| Lilly USA, LLC | 5 | $95 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| ABBVIE INC. | 3 | $50 |
| PFIZER INC. | 2 | $36 |
| Corcept Therapeutics | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $27 |
Products named: BREZTRI, YUPELRI, Ozempic, MOUNJARO, Wegovy, ELIQUIS, SHINGRIX, QULIPTA.
Industry payments across IL — which companies pay providers there.
